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ABSTRACT 
Various interventions have been employed for managing patients with temporomandibular 
joint (TMJ) disc displacement without reduction (DDwoR), but their clinical effectiveness 
remains unclear. This systematic review investigated the effects of these interventions and is 
reported in accordance with the PRISMA guidelines. Electronic and manual searches until 
1
st
/ November/2013 were conducted for English language, peer-reviewed, publications of 
randomised clinical trials comparing any form of conservative or surgical interventions for 
patients with clinical and/or radiological diagnosis of acute or chronic DDwoR. Two primary 
outcomes (TMJ pain intensity and maximum mouth opening) and a number of secondary 
outcomes were examined. Two reviewers performed data extraction and risk-of-bias 
assessment. Data collection and analysis were performed according to Cochrane 
recommendations. Twenty studies involving 1305 patients were included. Data analysis 
involved 21 comparisons between a variety of interventions, either between interventions, or 
between intervention and placebo or no intervention. Meta-analysis on homogenous groups 
was conducted in 4 comparisons. In most comparisons made, there were no statistically 
significant differences between interventions relative to primary outcomes at short- or long-
term follow-up (p>0.05). In a separate analysis, however, the majority of reviewed 
interventions improved primary outcome measures from their baseline levels significantly 
over time (p<0.05). Evidence levels are, however, currently insufficient for definitive 
conclusions because the included studies were too heterogeneous and at an unclear to high 
risk-of-bias. In view of the comparable therapeutic effects, paucity of high-quality evidence, 
and the greater risks and costs associated with more complex interventions, patients with 
symptomatic DDwoR should be initially treated using the simplest and least invasive 
intervention. 
INTRODUCTION 
Temporomandibular joint (TMJ) disc displacement without reduction (DDwoR) is a specific 
temporomandibular disorder (TMD) that can cause TMJ pain and limited mouth opening 
(painful locking), sometimes called a “closed lock” (Okeson, 2007). DDwoR can be acute or 
chronic depending on the duration of locking (Sembronio et al., 2008; Saitoa et al., 2010). Its 
incidence amongst TMD patients is estimated at 2-8% (Manfredini et al., 2011; Poveda-Roda 
et al., 2012). 
Various interventions have been suggested for DDwoR, but to-date, the most 
efficacious/effective approach is still unclear, which may result in management being based 
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more on experience than evidence (Durham et al., 2007). The aim of this systematic review 
was, therefore, to investigate the effects of different conservative and surgical interventions 
used in the management of TMJ DDwoR. 
METHODS 
Protocol and Registration 
This systematic review was conducted in accordance with the Cochrane Collaboration 
(Higgins and Green, 2011) and the Centre for Reviews and Dissemination (Akers et al., 
2009) guidance, and reported according to the PRISMA statement (Moher et al., 2009). All 
the methods of data collection/analysis and inclusion/exclusion criteria were pre-specified 
and documented in the review protocol (Al-Baghdadi et al., 2012). 
Criteria for Considering Studies (PICOS, Appendix-1) 
 Participants: Any age, gender with clinical and/or radiological diagnosis of acute or 
chronic DDwoR. 
 Interventions: Any form of conservative or surgical interventions. 
 Comparators/Control: Any alternative intervention, placebo, or no treatment. 
 Outcomes: Primary outcomes: TMJ pain intensity and unassisted/active maximum 
mouth opening (MMO). Secondary outcomes: other mandibular movements, 
mandibular function or patient’s quality-of-life, therapy cost, operation/admission 
duration in surgical trials, and adverse events. The outcomes were evaluated over 
short-term (≤3months) and long-term (>3months) follow-up periods. 
 Studies: Randomised and quasi-randomised clinical trials (RCTs and q-RCTs).  
Search Strategy (Appendix-2) 
Four databases were electronically-searched: CENTRAL; MEDLINE; EMBASE; Scopus till 
1
st
/November/2013. Other sources were manually-searched: citation search and reference lists 
of included studies, reference lists of relevant review articles and textbooks’ chapters, and 
seven journals highly likely to contain studies relevant to the review topic. 
Data Collection and Analysis  
Selection of Studies  
Eligible studies were selected according to the inclusion/exclusion criteria. Irrelevant reports 
were identified by their title/abstract and were excluded by the first reviewer (MA). The full-
texts of all potentially eligible studies were retrieved and independently examined in-
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duplicate by two reviewers (MA&JD) to establish eligibility. Throughout the whole process 
of this review, disagreements were resolved by consensus or, when necessary, by a third 
reviewer (JS). Studies excluded at this stage were identified and reasons for exclusion 
recorded.  
Data Extraction and Management  
A standardised, pre-piloted, extraction form based on Cochrane recommendations was 
employed. Eligible studies’ data were extracted and recorded by the first reviewer (MA). The 
second reviewer (JD), blinded to the authors’ names, institutions, and journal, crosschecked 
all extracted data’s validity. Authors of included studies were contacted to clarify study 
design and/or request missing data as required. 
Risk-of-bias Assessment 
The methodological quality of included studies was assessed independently and in-duplicate 
by two reviewers (MA&JD ‘blinded’) using the Cochrane risk-of-bias tool (Higgins et al., 
2011). Each domain in the tool was allocated one of the following judgments: low, unclear, 
or high risk-of-bias. Sample size calculation was also examined. 
Data Analysis 
The planned data analysis for this review was performed according to Cochrane statistical 
guidelines (Higgins and Green, 2011) using the Review Manager Software (version 5.2) 
(RevMan, 2012) comparing between the effects of different interventions (i.e. between-group 
statistical differences). For dichotomous data, the estimates of effect of an intervention were 
expressed as risk ratios (RR) together with 95% confidence intervals (CI). For continuous 
data, mean differences (MD) with 95% CI were used. Clinical and statistical heterogeneities 
were assessed across the studies prior to pooling. Clinical heterogeneity was determined by 
examining each study’s clinical characteristics for any diversity/variation in for example: 
technique/delivery of interventions, severity/chronicity of condition, and treatment outcomes. 
Statistical heterogeneity was assessed by Chi
2
 and I
2
 statistics (Higgins and Thompson, 
2002). A significant p-value<0.05 for Chi
2
 test and an I
2
 statistic>50% were considered 
substantial heterogeneity (Deeks et al., 2011). Pooling of clinically and statistically 
homogeneous trials was done by a fixed-effect model if there were two studies pooled and by 
a random-effects model if more than two studies pooled. When there was substantial 
heterogeneity between studies, meta-analysis was not undertaken and the data were integrated 
into a narrative analysis of the findings. A test for funnel plot asymmetry to assess 
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publication bias (Egger et al., 1997) was planned, but was not performed due to insufficient 
numbers of studies pooled in the meta-analyses. Where possible, a subgroup-analysis based 
on chronicity of the locking condition (acute or chronic: according to duration of locking 
threshold for chronic lock where disc recapture much less likely estimated at 4weeks) was 
conducted. Studies, without soft tissue imaging confirming the DDwoR clinical diagnosis, 
were excluded in a sensitivity-analysis to identify any effect on primary outcomes in the 
meta-analysis. 
Additional data analysis was also performed examining the change from baseline in primary 
outcomes for each individual intervention at short- and long-term follow-ups (i.e. within-
group statistical difference from baseline). This separate analysis was performed to help 
readers interpret the potential clinical significance of improvement from baseline for each 
intervention. 
RESULTS 
Search 
The search strategy identified a total of 3333 records from all databases. Of these, the full-
texts of 172 potentially eligible papers were retrieved and examined. Figure-1 illustrates the 
screening process. 
Description of Studies 
Twenty studies met the inclusion criteria (Lundh et al., 1992; Petersson et al., 1994; Linde et 
al., 1995; Fridrich et al., 1996; Schiffman et al., 1996; Goudot et al., 2000; Holmlund et al., 
2001; Minakuchi et al., 2001; Yuasa and Kurita, 2001; Maloney et al., 2002; Peroz et al., 
2004; Yoshida et al., 2005; Ismail et al., 2007; Politi et al., 2007; Schiffman et al., 2007; 
Diracoglu et al., 2009; Haketa et al., 2010; Yoshida et al., 2011; Craane et al., 2012; 
Sahlstrom et al., 2013). Summary characteristics of included studies are available in 
Appendix-3. The list of excluded studies and reasons for exclusion is available upon request.  
Risk-of-bias 
None of the included studies were at low risk-of-bias across all domains (Appendix-4). Eight 
were assessed as at unclear overall risk-of-bias due to insufficient information in the trial 
report and/or from the contacted authors, or because it was not possible to make a definite 
judgement in at least one domain of the bias assessment tool. The remaining studies were 
assessed as at high overall risk-of-bias. Of the twenty studies included, seven presented a 
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priori sample-size calculation and eight had inadequate statistical power (<80%) (Appendix-
3). 
Effects of Interventions 
The reviewed interventions varied widely in invasiveness. For the purpose of this review, the 
interventions were grouped based on their level of invasiveness into three modalities 
(Appendix-5):  
1) Non-invasive (conservative) including: education, self-management, splint therapy, 
physiotherapy, and their combinations;  
2) Minimally-invasive including: arthrocentesis;  
3) Invasive (surgical) including: arthroscopic and open joint surgeries.  
Twenty-one comparisons were made between interventions. Data for the 21-comparison 
(between-group statistical analysis) are presented in the text with the primary outcomes 
described at short- and long-term follow-up time-points in Table-1. Data examining within-
group differences from baseline for primary outcomes (within-group statistical analysis) at 
short- and long-term follow-ups are tabulated and presented in Appendix-6 to allow readers 
to assess the potential clinical significance of differences. Data on all secondary outcomes are 
available upon request.  
Comparisons of non-invasive interventions 
 Mandibular manipulation (MM) versus control 
MM was compared against control in two studies with the main difference being the delivery 
of manipulation: by clinicians (Yoshida et al., 2005) or by patients (Yoshida et al., 2011). No 
extractable numerical data were available from the former study but the authors reported that 
172/204 (84%) patients in the MM group showed reduced pain and increased opening at 
1week. Of 172 improvers, 170 had 'acute' (≤4weeks) and 2 had 'chronic' (>4weeks) DDwoR. 
In Yoshida et al. (2011), the number of patients with MMO>38mm was significantly greater 
10minutes after self-MM and these ‘improvers’ also had a short duration of locking 
(Mean=35days) (Table-1, Comparison-1). 
 Jaw exercises versus education 
Craane et al. (2012) compared jaw manipulation by physiotherapists to education in DDwoR 
with/without limited opening. Jaw exercises demonstrated no additional effect over education 
alone on all measured outcomes over the short- or long-term (Table-1, Comparison-2). 
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 Self-management versus control 
Two studies compared self-management (self-exercise+self-care/medication) to no active 
treatment over the short-term (Minakuchi et al., 2001; Yuasa and Kurita, 2001). No 
statistically significant differences in all measured outcomes between self-management and 
education were demonstrated by Minakuchi et al. (2001) (Table-1, Comparison-3). In Yuasa 
and Kurita (2001), a greater number of patients experienced decreased pain and increased 
opening in the self-management group, but the difference was not statistically significant. In 
a subgroup-analysis, however, self-management demonstrated a statistically significant 
difference over no treatment with 'chronic' (>4weeks) DDwoR (Table-1, Comparison-4). 
 Self-management versus splint 
Haketa et al. (2010) compared self-management involving self-exercises (+self-
care/NSAIDs) to splint (+self-care/NSAIDs). Although there was greater reduction in pain 
intensity in the self-management group over the short-term, the difference was not 
statistically significant. For MMO, however, self-management demonstrated a statistically 
significant difference in effect over splint (Table-1, Comparison-5). 
 Splint versus control 
Lundh et al. (1992) made this comparison on patients diagnosed by arthrography and given 
information and pain medication as needed. The number of patients with reduced pain was 
significantly greater in untreated than those treated with splints over the long-term (Table-1, 
Comparison-6). 
 Splint versus transcutaneous electric nerve stimulation (TENS) 
In Linde et al. (1995), the number of patients with ≥50% pain reduction was significantly 
greater in the splint group than TENS group, but there was no statistically significant 
difference between the interventions on MMO over the short-term (Table-1, Comparison-7). 
TENS caused mild transient hypersensitivity preauricular skin reaction. 
 Combination therapy versus education 
Minakuchi et al. (2001) compared the short-term effect of combined splint plus exercises 
(+self-care/medication/education) to education only with no statistically significant 
differences in effect between the interventions on all measured outcomes (Table-1, 
Comparison-8). 
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 Combination therapy versus self-management 
Two studies compared combination therapy including splint plus exercises (+self-
care/medication/education±CBT) to self-management (self-care/medication/education±self-
exercises) (Minakuchi et al., 2001; Schiffman et al., 2007) with no statistically significant 
differences between the effects of the interventions on all measured outcomes over the 
longest follow-up (Table-1, Comparison-9). Pooling the data demonstrated no statistically 
significant differences between the short-term effects of the interventions on pain intensity 
(standardized mean differences (SMD)=0.22, 95%CI: -0.19 to 0.62, p=0.29) (Figure-2). 
 Combination of splint plus jaw exercises versus splint 
Two studies made this comparison on patients with “disc displacement” or osteoarthritis with 
the main difference being the delivery of jaw exercises: by clinicians (Ismail et al., 2007) or 
by patients using either a mechanical device (Therabite) or wooden tongue depressors 
(WTDs) (Maloney et al., 2002). Pooling the data showed no statistically significant 
difference in effects between the combined splint+exercises versus splint alone on pain over 
the short-term (MD=0.90, 95%CI: -12.28 to 14.07, p=0.89). For MMO, however, the meta-
analysis showed a statistically significant difference in effect in favour of the combined 
treatment (MD=4.67mm, 95%CI: 1.80 to 7.55, p<0.01) (Figure-3 and Table-1, Comparison-
10). 
 Active pulsed electromagnetic fields (PEMF) versus placebo PEMF 
In Peroz et al. (2004), active PEMF did not demonstrate additional effect over placebo on all 
measured outcomes in DDwoR patients over both short- and longer-term (Table-1, 
Comparison-11). 
 Active iontophoresis versus placebo iontophoresis  
In Schiffman et al. (1996), active iontophoresis by dexamethasone+lidocaine demonstrated 
greater short-term effects over placebo iontophoresis by normal saline on all measured 
outcomes but the differences were not statistically significant (Table-1, Comparison-12). 
Iontophoresis caused two types of mild transient adverse events (skin erythema and 
dizziness). 
Comparisons of minimally-invasive versus non-invasive interventions 
 Arthrocentesis versus control 
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Two studies evaluated the short-term effect of arthrocentesis to a control group: diagnostic 
arthrography (Petersson et al., 1994); auriculotemporal nerve (ATN) block as sham treatment 
(Sahlstrom et al., 2013). In both, arthrocentesis did not demonstrate statistically significant 
effect over the control groups on all measured outcomes (Table-1, Comparisons-13&-14). 
Pooling the data to evaluate the overall effect of arthrocentesis was not possible due to 
clinical (incomparable 'controls') and statistical (chi
2
<0.05; I
2
>50%) heterogeneity. 
 Arthrocentesis versus combination therapy 
Diracoglu et al. (2009) compared arthrocentesis to a combination of splint plus self-care/self-
exercises on patients with 'acute' DDwoR (≤4weeks). In this q-RCT, arthrocentesis 
demonstrated a statistically significant difference in effect over the combined treatment on 
pain over both short- and longer-term, but there was no statistically significant difference 
between the interventions on MMO (Table-1, Comparison-15). 
Comparisons of invasive versus non-invasive interventions 
 Arthroscopy versus conservative treatments 
Schiffman et al. (2007) compared arthroscopic surgery to two conservative treatment 
strategies: self-management (self-care/medication/education); combination of splint plus 
exercises (+self-care/medication/education+CBT). Arthroscopy did not demonstrate 
statistically significant differences in effect over conservative interventions on all measured 
outcomes over the short- or long-term (Table-1, Comparisons-16&-17). 
 Open surgery versus conservative treatments 
Schiffman et al. (2007) also compared open surgery with the same conservative 
interventions: self-management; combination therapy. Open surgery did not demonstrate 
statistically significant differences in effect over self-management on all measured outcomes 
over the short- or long-term (Table-1, Comparison-18). When compared with the 
combination therapy, open surgery demonstrated a statistically significant difference in effect 
on pain over the short-term, but not over the long-term (Table-1, Comparison-19). 
Comparison of invasive versus minimally-invasive interventions 
 Arthroscopy versus arthrocentesis 
Two studies made this comparison on patients with disc displacement with/without reduction 
(Fridrich et al., 1996; Goudot et al., 2000). In Goudot et al. (2000), no statistically significant 
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difference in effects between the interventions on pain over the long-term was demonstrated. 
For MMO, pooling the data resulted in a statistically significant difference in favour of 
arthroscopy over the long-term (MD=5.13mm, 95%CI: 3.20 to 7.06, p<0.001) (Figure-4 and 
Table-1, Comparison-20). Four surgical complications were reported by Goudot et al. (2000): 
two intra-operative complications in arthrocentesis group (2 severe reversible bradycardias) 
and two post-operative complications in arthroscopic group (transient frontal palsy and 
prolonged cervico-facial oedema). 
Comparison of invasive interventions 
 Open surgery versus arthroscopy 
Three studies made this comparison with no statistically significant differences between the 
effects of the two surgeries on all measured outcomes over the longest follow-up (Holmlund 
et al., 2001; Politi et al., 2007; Schiffman et al., 2007). When combined in meta-analysis, a 
significant overall effect for open surgery over arthroscopy on reducing the pain intensity 
over the long-term was demonstrated (SMD=-0.50, 95%CI: -0.95 to -0.06, p=0.03). 
However, sensitivity-analysis by excluding the study without confirmatory diagnostic 
imaging (Holmlund et al., 2001), showed no statistically significant difference between the 
surgical procedures (SMD=-0.43, 95%CI: -0.93 to 0.08, p=0.10). Furthermore, pooling the 
data from two studies (Holmlund et al., 2001; Politi et al., 2007) showed no statistically 
significant difference between the long-term effects of surgeries on number of patients with 
MMO>35mm (RR=1.07, 95%CI: 0.76 to 1.49, p=0.71) (Figure-5 and Table-1, Comparison-
21). Open surgery caused one transient motor nerve injury (Schiffman et al., 2007) and a 
number of transient sensory nerve injuries (Holmlund et al., 2001; Politi et al., 2007).  
DISCUSSION 
Summary of Main Findings 
There was high clinical heterogeneity amongst the studies included, which was unsurprising 
given the differing interventions employed, and the considerable variations in techniques 
applied, combinations, and/or delivery, of interventions. In most comparisons, therefore, 
there was only one trial and only four meta-analyses could be performed on trials of 
homogenous comparable groups. 
In this review, analysis was conducted between- and within-group. When the interventions 
were compared with each other (between-group), the least invasive conservative 
interventions including patient education and self-management seem to exert comparable 
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effects to more ‘active’ (combined splint plus physiotherapy) or ‘invasive’ (TMJ surgery) 
treatment approaches. Splints as a solitary treatment approach seem, however, to have no 
additional effect over other active interventions or no treatment, although as an adjunct to 
others, they may help to alleviate symptoms. 
Among the physiotherapeutic interventions, early mandibular manipulation seems to exert an 
immediate effect, increasing MMO in patients with ‘acute’ DDwoR. Jaw ‘stretching’ 
exercises, either alone or in combination with others, also increased MMO but its effect was 
inconsistent between studies whilst the electro-physical modalities had, in general, no 
significant effect over placebo treatment or splints and could be associated with transient 
adverse events.  
Minimally-invasive arthrocentesis and invasive arthroscopic and open joint surgical 
interventions did not, in general, demonstrate significant differences in effects over non-
invasive conservative interventions and could be associated with complications. 
Nevertheless, in one study, arthrocentesis reduced pain intensity more than conservative 
treatment in 'acute' DDwoR (Diracoglu et al., 2009). The study, however, used quasi-
randomization based on alternate allocation to intervention groups and if excluded from this 
review, arthrocentesis is not proven to have additional effects over conservative 
interventions. When compared with each other, arthroscopy increased MMO more than 
arthrocentesis and open surgery reduced pain intensity more than arthroscopy. In the latter 
comparison, sensitivity-analysis did not confirm this finding suggesting the result is unstable 
and the evidence is not robust. The surgical procedures also suffered from clinical 
heterogeneity in: anaesthetic modality; lavage volumes (50-150ml) sometimes less than 
recommended (100-400ml) (Zardeneta et al., 1997; Kaneyama et al., 2004); surgical 
techniques; intra-articular medications injected; intra- and/or post-operative jaw 
manipulation, making circumstances incomparable and any direct comparison difficult. 
Previous Cochrane reviews for arthrocentesis (Guo et al., 2009) or arthroscopy (Rigon et al., 
2011) included 7 studies which were either included within the present review (5 studies), or 
did not meet our inclusion criteria (2 studies). The current review’s findings concur with 
these reviews in that: non-invasive conservative interventions need to be applied first; there is 
insufficient evidence to support or refute the use of minimally-invasive and invasive surgical 
interventions; there is a need for higher-quality RCTs.  
Overall, the between-group analysis shows no statistically significant differences in effects 
between most of the compared interventions. The differences in effect between interventions 
seem to be minimal thereby replicating/confirming results from a previous review (Kropmans 
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et al., 1999). In contrast, the within-group analysis for difference from baseline caused by 
each individual intervention shows that most interventions caused a statistically significant 
improvement in primary outcomes over the short- and long-term. Most analysed 
interventions, therefore, seem to be effective in alleviating DDwoR symptoms (decreased 
pain and increased opening) to a greater or lesser degree. These findings, however, highlight 
three issues: 
Firstly: The improvement in patients’ symptoms regardless of treatment-specific effects could 
be due to placebo effects (Greene et al., 2009) or the ‘favourable’ natural course of DDwoR 
(Sato et al., 1997; Kurita et al., 1998; Yura, 2012). In this review, most studies did not have a 
'true' untreated control group and therefore the estimate of the intervention’s effect should be 
interpreted with caution as it may be due to placebo effects and/or adaptation over time.   
Secondly: Some included studies were found to be underpowered to detect statistically 
significant differences between the compared interventions. Insufficient power usually 
indicates ‘poor’ methodological quality, for example Petersson et al. (1994) would have 
needed a reasonable sample size (~48 patients in each treatment group) to achieve adequate 
power. It also, however, can confirm the minimal therapeutic difference between 
interventions’ effects, for example Holmlund et al. (2001) would have needed a very large, 
and unrealistic, sample size (~132 patients in each treatment group) to achieve adequate 
power. This would have been highly impractical in a single-centre study of a low incidence 
condition (DDwoR). 
Thirdly: Despite the absence of statistically significant differences between interventions, 
most interventions caused statistically significant improvement from baseline thereby posing 
the question: is this improvement clinically meaningful? To answer such a question we must 
understand the minimal clinically important difference (MCID) determined from the patient’s 
perspective (Copay et al., 2007) for the primary outcomes. For pain intensity, the MCID has 
been defined as a reduction from baseline of approximately one third (~30%): 2-point on an 
11-point numerical rating scale (Farrar et al., 2001); 20mm on a 100mm visual analogue 
scale (Jensen et al., 2003). In this review, however, pain intensity was measured using 
different instruments (tools/scales), which may not be directly comparable. For MMO, 
Kropmans et al. (2000) suggests an increase of at least 9mm to demonstrate a statistical and 
clinical improvement in MMO. Kropmans et al.’s study had several methodological flaws 
and the 9mm threshold was based on the smallest detectable difference in measurements for 
assisted/passive MMO in untreated patients with “painfully restricted TMJ disorders”. This is 
as opposed to a MCID in MMO, which would require assessment from the patient’s 
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perspective as a result of therapeutic intervention (Dworkin et al., 2008). There is, therefore, 
no currently agreed MCID for MMO and further studies using biopsychosocially 
representative samples of subjects with DDwoR are needed to address this. Nevertheless, if 
the 9mm for assisted/passive MMO improvement is taken as perhaps indicative of MCID, 
one could estimate an increase from baseline of about 6.5mm or more for unassisted/active 
MMO (~2.5mm difference between unassisted and assisted MMO for DDwoR patients 
(Hesse et al., 1996) due to joint laxity and passive stretch force). The suggested values can be 
used as an approximate to help readers interpret the clinical significance of change from 
baseline reported in Appendix-6. 
The study samples included in this review also had limitations. Most subjects included were 
female (87%) with a mean age of 35years thereby mirroring closed lock reviews (Al-Belasy 
and Dolwick, 2007; Monje-Gil et al., 2012) but they were: mostly recruited from specialised 
university clinics/hospitals as opposed to other first-point contact clinical-settings; differed in 
the presence/absence of comorbid disorders; differed in duration of DDwoR symptoms (one 
day to several years). All these factors may have affected the magnitude of treatment effect 
due to possible variation in the level of pathological changes in the intra-articular tissues 
(Stiesch-Scholz et al., 2002; Emshoff and Rudisch, 2004; Machon et al., 2012) amongst other 
variables. To investigate this, a threshold of 4weeks locking duration was estimated for 
acute/chronic DDwoR subgroup analysis. Few analyses could be conducted using this 
threshold and the effect of locking duration on effectiveness of interventions could not be 
established. 
Most included studies had methodological flaws in their design and used different methods to 
assess subjective outcomes. This made comparisons of the effect-size of interventions 
difficult. Furthermore, none of them captured the broad multidimensional nature of patients' 
quality-of-life (Locker and Allen, 2007) and only one evaluated the therapy cost (Schiffman 
et al., 2014). Future trials need to address these outcomes and should follow the IMMPACT 
recommendations for outcomes assessment in pain clinical trials (Dworkin et al., 2005) and 
CONSORT guidelines for RCT conduct and reporting (Schulz et al., 2011). 
Despite the aforementioned limitations, one issue has become apparent from the results of 
this review: most interventions appear to alleviate DDwoR symptoms with no significant 
differences between non-invasive conservative interventions and minimally-invasive or 
invasive surgical interventions. Given the paucity of evidence and the difficulty in 
interpreting the minimal clinically important difference, this finding suggests that patients 
with DDwoR probably should be initially managed with the most minimal and least invasive 
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intervention. Escalation to more invasive treatment should only occur in the face of objective 
clinical need. This, however, should be interpreted in the context of a review based mostly on 
single studies of unclear to high risk-of-bias. Future well-conducted research may change or 
confirm this. 
CONCLUSIONS  
Implications for Practice 
The comparable therapeutic effects of reviewed interventions suggest using the simplest, least 
costly, and least invasive interventions to initially manage DDwoR. Of the variety of non-
invasive conservative interventions reviewed, the least invasive were patient education, self-
management, and early mandibular manipulation. Currently, there is insufficient evidence to 
support or refute the use of minimally-invasive and invasive surgical interventions for 
DDwoR. There may well be, however, specific clinical cases where a surgical intervention 
may help, but the body of evidence does not give a clear indication of when this may be. 
Implications for Research  
There is weak evidence to support the initial use of simple, minimal, non-invasive 
conservative interventions, in particular patient education, self-management, and early 
mandibular manipulation, for DDwoR. Future research needs to specifically examine these 
interventions to provide more robust evidence of their efficacy or lack of it. The evidence for 
the effectiveness of minimally-invasive surgical intervention through arthrocentesis and 
lavage is contradictory. Given its less invasive nature, future high-quality pragmatic RCTs 
are required to compare the effects of arthrocentesis with conservative interventions.  
Detailed descriptions about recommended research design are available upon request.  
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Table 1: Summary of findings for the primary outcomes (pain at jaw function and unassisted/active maximum mouth opening). 
Comparison 
(Study) 
Primary 
outcome 
Follow-up 
(short-term 
& long-term) 
No. of 
Patients 
(Trials) 
Relative effect (95% CI)a 
p-value for between-
group differenceb 
Overall 
Risk-of-
Bias 
Outcome 
measuring 
tool/scalec 
1. MM vs. No treatment 
(Yoshida et al., 2011) 
MMO  10 min (ST) 148 (1 RCT) RR 16.67 (5.44 to 51.06) p<0.0001 favours MM High MMO>38mm 
2. Jaw exercises vs. 
Education only 
(Craane et al., 2012) 
Paind 3 mo (ST) 42 (1RCT) MD 3.81 (-6.15 to 13.77) NS Unclear VAS (0-100) 
Paind 13 mo (LT) 42 (1 RCT) MD 0.62 (-5.46 to 6.70) NS Unclear VAS (0-100) 
MMO 3 mo (ST) 45 (1 RCT) MD -3.10 (-6.96 to 0.76) NS Unclear aMMO (mm) 
MMO 13 mo (LT) 42 (1 RCT) MD -3.80 (-7.68 to 0.08) NS (p=0.05 towards Educ) Unclear aMMO (mm) 
3. Self-management vs. 
Education only 
(Minakuchi et al., 2001) 
Pain 2 mo (ST) 44 (1 RCT) MD -4.40 (-19.54 to 10.74) NS Unclear 
VAS (0-100) 
on chewing 
MMO 2 mo (ST) 44 (1 RCT) MD -1.40 (-6.90 to 4.10) NS Unclear aMMO (mm) 
4. Self-management vs. 
No treatment 
(Yuasa and Kurita, 2001) 
Pain & 
MMO 
1 mo (ST) 60 (1 RCT) RR 1.80 (1.00 to 3.23) NS (p=0.05 towards SM) 
Unclear 
No. improved 
patients for: 
VAS pain & 
MMO 
Subgroup 
analysis  
1 mo (ST) 
   15 Acute RR 1.05 (0.57 to 1.94) NS 
45 Chronic RR 2.51 (1.06 to 5.95) p<0.05 favours SM 
5. Self-management vs. 
Splint 
(Haketa et al., 2010) 
Pain 2 mo (ST) 44 (1 RCT) MD -15.20 (-31.55 to 1.15) NS (p=0.07 towards SM) Unclear VAS (0-100) 
MMO 2 mo (ST) 44 (1 RCT) MD 6.00 (2.67 to 9.33) p<0.001 favours SM Unclear 
MMO with 
pain (mm) 
6. Splint vs. Control 
(Lundh et al., 1992) 
Pain 12 mo (LT) 51 (1 RCT) RR 0.49 (0.26 to 0.92) p<0.05 favour Control High 
No. reduced 
pain 
7. Splint vs. TENS 
(Linde et al., 1995) 
Pain 6 wk (ST) 31 (1 RCT) RR 8.53 (1.21 to 60.33) p<0.05 favours Splint High 
Reduction in 
pain≥50% 
MMO 6 wk (ST) 31 (1 RCT) MD -0.16 (-4.07 to 3.75) NS High 
Change from 
baseline mm 
8. Combination therapye 
vs. Education only 
(Minakuchi et al., 2001) 
Pain 2 mo (ST) 46 (1 RCT) MD -2.80 (-16.12 to 10.52) NS Unclear 
VAS (0-100) 
on chewing 
MMO 2 mo (ST) 46 (1 RCT) MD 1.40 (-3.94 to 6.74) NS Unclear aMMO (mm) 
9. Combination therapy 
vs. Self-management 
(Minakuchi et al., 2001; 
Schiffman et al., 2007) 
Pain 2-3 mo (ST) 97 (2 RCTs) SMD 0.22 (-0.19 to 0.62) NS Unclear VAS & SSI 
Pain 60 mo (LT) 50 (1 RCT) MD 0.00 (-0.13 to 0.13) NS Unclear SSI (0-1) 
MMO 2 mo (ST) 48 (1 RCT) MD 2.80 (-2.95 to 8.55) NS Unclear aMMO (mm) 
10. Jaw exercise + splint vs. 
Splintf 
(Maloney et al., 2002; 
Ismail et al., 2007) 
Pain 1-3 mo (ST) 50 (2 RCTs) MD 0.90 (-12.28 to 14.07) NS High 
VAS & NRS 
(0-100) 
MMO 1-3 mo (ST) 50 (2 RCTs) MD 4.67 (1.80 to 7.55) p<0.01 favours Ex+Sp High aMMO (mm) 
11. Active PEMF vs.  
Placebo PEMF 
(Peroz et al., 2004) 
Paind 6 wk (ST) 31 (1 RCT) MD 0.23 (-17.96 to 18.42) NS Low VAS (0-100) 
Paind  4 mo (LT) 30 (1 RCT) MD 19.49 (0.97 to 38.01) p<0.05 favour placebo Unclear VAS (0-100) 
MMOd 6 wk (ST) 31 (1 RCT) MD -2.47 (-8.23 to 3.29) NS Low aMMO (mm) 
MMO 4 mo (LT) 30 (1 RCT) MD -1.00 (-6.09 to 4.09) NS Unclear aMMO (mm) 
12. Active iontophoresis vs. 
Placebo iontophoresisg 
(Schiffman et al., 1996) 
Pain  1 wk (ST) 18 (1 RCT) MD -0.03 (-0.21 to 0.15) NS Unclear SSI (0-1) 
MMO  1 wk (ST) 18 (1 RCT) MD 1.90 (-5.70 to 9.50) NS Unclear aMMO (mm) 
13. Arthrocentesis vs. 
Arthrography only 
(Petersson et al., 1994) 
Painh 2 mo (ST) 33 (1 RCT) MD -16.02 (-34.79 to 2.75) NS (p=0.09 towards AC) High 
VAS (0-100) 
after chewing 
MMO 2 mo (ST) 33 (1 RCT) MD -3.00 (-9.54 to 3.54) NS High mm 
14. Arthrocentesis vs.   
ATN LA block 
(Sahlstrom et al., 2013) 
Paind  
(no ITT) 
3 mo (ST) 37 (1 RCT) MD 24.60 (6.06 to 43.14) p<0.01 favours LA Unclear 
VAS (0-100) 
at movements 
Pain 
(ITT) 
3 mo (ST) 45 (1 RCT) RR 0.72 (0.46 to 1.14) NS Unclear 
Reduced 
pain≥30% 
MMOd 3 mo (ST) 37 (1 RCT) MD -4.90 (-10.00 to 0.20) NS (p=0.06 towards LA) Unclear aMMO (mm) 
15. Arthrocentesis vs. 
Combination therapy 
(Diracoglu et al., 2009) 
Pain  3 mo (ST) 110 (1 qRCT) MD -19.3 (-28.54 to -10.06) p<0.0001 favours AC  High VAS (0-100) 
Pain  6 mo (LT) 110 (1 qRCT) MD -28.80 (-36.56 to -21.04) p<0.0001 favours AC High VAS (0-100) 
MMO  3 mo (ST) 110 (1 qRCT) MD 1.93 (-0.75 to 4.61) NS High mm 
MMO  6 mo (LT) 110 (1 qRCT) MD 2.35 (-0.07 to 4.77) NS (p=0.06 towards AC) High mm 
16. Arthroscopy vs.          
Self-management 
(Schiffman et al., 2007) 
Pain 3 mo (ST) 50 (1 RCT) MD 0.01 (-0.12 to 0.14) NS Unclear SSI (0-1) 
Pain  60 mo (LT) 51 (1 RCT) MD 0.03 (-0.09 to 0.15) NS Unclear SSI (0-1) 
17. Arthroscopy vs. 
Combination therapy 
(Schiffman et al., 2007) 
Pain  3 mo (ST) 43 (1 RCT) MD -0.08 (-0.24 to 0.08) NS Unclear SSI (0-1) 
Pain  60 mo (LT) 47 (1 RCT) MD 0.03 (-0.09 to 0.15) NS Unclear SSI (0-1) 
18. Open surgery vs.        
Self-management 
(Schiffman et al., 2007) 
Pain  3 mo (ST) 48 (1 RCT) MD -0.07 (-0.20 to 0.06) NS Unclear SSI (0-1) 
Pain 60 mo (LT) 50 (1 RCT) MD 0.05 (-0.09 to 0.19) NS Unclear SSI (0-1) 
19. Open surgery vs. 
Combination therapy 
(Schiffman et al., 2007) 
Pain  3 mo (ST) 41 (1 RCT) MD -0.16 (-0.32 to -0.00) p<0.05 favours OS Unclear SSI (0-1) 
Pain 60 mo (LT) 46 (1 RCT) MD 0.05 (-0.09 to 0.19) NS Unclear SSI (0-1) 
20. Arthroscopy vs. 
Arthrocentesis 
(Fridrich et al., 1996; 
Goudot et al., 2000) 
Pain  12 mo (LT) 62 (1 RCT) MD 10.00 (-1.20 to 21.20) NS (p=0.08 towards AC) High VAS (0-100) 
MMO  6-24 mo (LT) 81 (2 RCTs) MD 5.13 (3.20 to 7.06) p<0.0001 favours AS High mm 
21. Open surgery vs. 
Arthroscopy 
(Holmlund et al., 2001; 
Politi et al., 2007; 
Schiffman et al., 2007) 
Pain  3 mo (ST) 42 (1 RCT) MD -0.08 (-0.23 to 0.07) NS Unclear SSI (0-1) 
Pain  12 mo (LT) 81 (3 RCTs) SMD -0.50 (-0.95 to -0.06) p<0.05 favours OS High VAS & SSI 
Sensitivity 
analysis 
12 mo (LT) 61 (2 RCTs) SMD -0.43 (-0.93 to 0.08) NS High VAS & SSI 
MMO  12 mo (LT) 40 (2 RCTs) RR 1.07 (0.76 to 1.49) NS High MMO>35mm 
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Abbreviations: AC: arthrocentesis, aMMO: active (unassisted) maximum mouth opening, AS: arthroscopy, ATN LA block: 
auriculotemporal nerve local anaesthesia block, CI: confidence interval, Educ: education, Ex+Sp: exercises plus splint, ITT: intention-to-
treat analysis, LT: long-term, MD: mean difference, min: minutes, MM: mandibular manipulation, mm: millimetres, MMO: maximum 
mouth opening, mo: months, No.: number of patients, NRS: numerical rating scale, NS: non-significant, OS: open surgery, PEMF: pulsed 
electromagnetic fields, qRCT: quasi-randomised clinical trial, RCT: randomised clinical trial, RR: risk ratio, SM: self-management, SMD: 
standardised mean difference, SSI: symptoms severity index, ST: short-term, TENS: transcutaneous electric nerve stimulation, VAS: visual 
analogue scale, wk: weeks.  
a The risk ratio (RR) is the ratio of the chance of experiencing a particular event that occurs with use of the intervention to that occurs with 
the use of control. The mean difference (MD) is the difference in means values between two groups in a clinical trial. It estimates the 
amount by which an intervention changes the outcome on average compared with the control. It can be used as a summary statistic in meta-
analysis when outcome measurements in all studies are made on the same scale. The standardized mean difference (SMD) is used as a 
summary statistic in meta-analysis when the studies all assess the same outcome but measure it on different scales. It expresses the size of 
the intervention effect in each study relative to its variance (SD). Further details about the statistical analysis used to measure the relative 
effects of interventions in clinical trials are available in the Cochrane handbook for systematic reviews of interventions which is accessible 
online: http://handbook.cochrane.org/.  
b Statistical significance (p-value<0.05) for between-group statistical differences. 
c For uniformity, data were analysed and presented by rescaling pain scales (VAS and NRS) on 0-10 cm (Goudot et al., 2000; Holmlund et 
al., 2001; Maloney et al., 2002; Politi et al., 2007; Diracoglu et al., 2009) to a 0-100 mm scale.  
d Unpublished statistical data provided by the contacted authors (personal e-mail communication). 
e Combination therapy of splint plus jaw exercises (± self-care/education/medication ± cognitive behavioural therapy ‘CBT’) conservative 
interventions. 
f In Maloney et al. (2002), Therabite devise + splint group and wooden tongue depressors (WTDs) + splint group were merged as one group: 
jaw exercises plus splint. 
g In Schiffman et al. (1996), three groups were compared (active iontophoresis by dexamethasone + lidocaine, control iontophoresis by 
lidocaine only, and placebo iontophoresis by normal saline). In this review, however, only the comparison between active and placebo 
iontophoresis was considered and reported. 
h Estimated from figure 2 in the published trial. 
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Figure legends:  
Figure 1: Study flow diagram. 
 
 
 
Figure 2: Forest plot* of pooled data regarding pain outcome for combination therapy versus 
self-management. 
* Guidance for interpreting forest plots can be found in (Lewis and Clarke, 2001). 
 
 
 
Figure 3: Forest plot of pooled data regarding pain and mandibular movements outcomes for 
combination of splint plus jaw exercises versus splint only. 
 
 
 
Figure 4: Forest plot of pooled data regarding maximum mouth opening outcome for 
arthroscopy versus arthrocentesis. 
 
 
 
Figure 5: Forest plot of pooled data regarding pain, mandibular movements, and function 
outcomes for open joint surgery versus arthroscopic surgery. 
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Title: TMJ Disc Displacement without Reduction Management: A Systematic Review 
APPENDICES 
Systematic Review Methods (Details)* 
Appendix 1 (Table). Inclusion/Exclusion Criteria 
Inclusion criteria Exclusion criteria 
Types of studies Types of studies 
Randomised clinical trials (RCTs) that involve patients with TMJ DDwoR and comparing any 
form of conservative (non-surgical) or surgical interventions against each other, placebo or no 
treatment.  
Quasi-randomised studies, such as those allocating patients by using alternate days of the 
week, birth date, or consecutive attendance considered only if the baseline demographic details 
(e.g., severity of condition) of each comparable group were approximately similar. Included 
quasi-random trials were, however, subject to a sensitivity analysis. 
Studies which involve other heterogeneous groups of TMD patients (e.g. osteoarthritis, 
myofacial pain, disc displacement with reduction) in addition to patients with DDwoR were 
considered only if separate data were provided for DDwoR patients. If the separate data had 
not been provided but the percent of DDwoR patients in the study sample was more than 70%, 
the study was examined to be included. 
Studies comparing different types or techniques of similar intervention group (such as trials 
comparing different techniques of arthroscopy, different techniques of arthrocentesis, or those 
comparing between different types of occlusal splints). 
Studies evaluating a treatment modality after an initial surgical intervention (such as trials 
evaluating different medications or splints after arthroscopy or arthrocentesis). 
Types of participants Types of participants 
Patients of any age, gender, and of all degree of severity with clinical and/or radiological 
diagnosis of TMJ DDwoR as diagnosed according to: American Association of Orofacial Pain 
(AAOP) guidelines for acute or chronic DDwoR (de Leeuw, 2008); research diagnostic criteria 
for temporomandibular disorders (RDC/TMD) for DDwoR with (IIb) or without (IIc) limited 
mouth opening (Dworkin and LeResche, 1992); Wilkes staging for internal derangement (stage 
III or IV) (Wilkes, 1989); or any other compatible criteria for DDwoR diagnosis. Confirming 
the disc position by soft tissue imaging was not a prerequisite to include the study. 
Studies which involve participants with confirmed diagnosis of DDwoR disorder with 
comorbid disorders. 
Patients with systemic diseases. 
Types of interventions Types of interventions 
Different forms of conservative (non-surgical) and surgical therapeutic interventions such as: 
patient education, self-management, psychosocial therapy, pharmacological therapy, 
physiotherapy, splint therapy, intra-articular medication injection, arthrocentesis, arthroscopic 
surgery, and open joint surgery. 
Studies that evaluate these therapeutic interventions against each other, placebo or no treatment 
were included. Standardized combinations of treatments were also included. 
Studies comparing different types or techniques of similar intervention group. 
Studies evaluating a treatment modality after an initial surgical intervention. 
* Further details about the review methods are available in the study protocol registered at PROSPERO-CRD database (Al-Baghdadi et al., 2012). 
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Appendix 2. Search Strategy 
Electronically-searched databases:  
1. Cochrane Central Register of Controlled Trials (CENTRAL) via Cochrane Library (November/2013 issue);  
2. MEDLINE via Ovid (1966-November/2013);  
3. EMBASE via Ovid (1980-November/2013);  
4. Scopus via SciVerse (1966-November/2013). 
Limits: English-language, peer-reviewed, publications.  
The search strategy was primarily developed for the MEDLINE (see below) and was revised appropriately for 
each database searched to take account of differences in controlled vocabulary and syntax rules.  
Ovid MEDLINE(R) <1966 to October Week 4 2013> 
1. exp Temporomandibular Joint disorders/ 
2. exp Temporomandibular Joint/ 
3. 1 or 2 
4. (temporomandibular joint or tmj).tw. 
5. (derangement adj6 (disorder$ or condition$)).tw. 
6. (derangement adj2 internal).tw. 
7. (lock$ adj2 (closed or jaw)).tw. 
8. ((displace$ or dislocat$ or unreduc$ or nonreduc$ or un-reduc$ or non-reduc$ or derange$) adj6 (disc or disk or 
meniscus)).tw. 
9. or/4-8 
10. 3 and 9 
The above subject search was linked to the Cochrane Highly Sensitive Search Strategy (CHSSS) for identifying randomised 
controlled trials (RCTs) in MEDLINE: sensitivity maximising version (2008 revision) as referenced in Chapter 6.4.11.1 and 
detailed in box 6.4.c of the Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0 (updated March 
2011) (Higgins and Green, 2011): 
1. randomized controlled trial.pt. 
2. controlled clinical trial.pt. 
3. randomized.ab. 
4. placebo.ab. 
5. drug therapy.fs. 
6. randomly.ab. 
7. trial.ab. 
8. groups.ab. 
9. or/1-8 
10. exp animals/ not humans.sh. 
11. 9 not 10 
Hand-searched Journals: 
1. Journal of Oral and Maxillofacial Surgery (from 2010 to October 2012). 
2. Cranio: The journal of craniomandibular practise (from 1996 to October 2012). 
3. Journal of Prosthetic Dentistry (from 1999 to September 2012). 
4. Journal of Oral Rehabilitation (from 2004 to October 2012). 
5. Journal of Orofacial Pain (from 1987 to December 2012). 
6. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology (from 2004 to February 2012). 
7. International Journal Oral and Maxillofacial Surgery (from 2003 to October 2012). 
These journals were hand-searched by the first reviewer (MA) according to dates not already have been hand-
searched by the Cochrane worldwide hand-searching programme (according to Master List of journals 
completed search by the Cochrane Oral Health Group to October 2012).
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Systematic Review Results 
Appendix 3 (Table). Characteristics of Included Studies (Studies in Chronological Order) 
Study 
(year) 
Study design Participants 
Interventions 
Follow-up 
time-points 
Main assessed 
outcomes 
Adverse 
events 
Dropouts 
(groups) Allocation Blinding 
Setting, 
Country 
Fund 
Sample size 
(PA used?)a 
Age 
(years) 
Gender 
Locking 
duration 
Diagnostic 
criteria 
ST 
imaging 
Lundh et al. 
(1992) 
Random NR 
University, 
Sweden 
Yes 
51 
(No) 
Mean 
29 
5m,46f NR 
Eriksson 
criteriab 
Arthrogr. 
Splint, N=25 
Control, N=26 
6, 12 mo Pain NR No 
Petersson et 
al. (1994) 
Random 
Single-
blind 
University, 
Sweden 
NR 
34 
(No) 
Mean 
33 
5m,29f NR 
Eriksson 
criteriab 
Arthrogr. 
Arthrocentesis, N=16/17 
Arthrography, N=17 
2 mo 
Pain, MMO, 
LM, PM, Self-
questionnaire 
No 
Total=1 
(AC=1) 
Linde et al. 
(1995) 
Random NR 
University, 
Sweden 
Yes 
33 (2 exc) 
(No) 
Median
37 
5m,26f 
Median 6mo 
(range 2wk-
16yr) 
Own study 
criteria 
No 
TENS, N=16/17 
Splint, N=15 
6 wk 
Pain, MMO, 
LM, PM, 
Frequency and 
severity of 
complaints 
Yes 
(TENS: 
unclear) 
Total=2: 
(TENS=1, 
unclear=1) 
Fridrich et al. 
(1996) 
Random NR 
University, 
USA 
NR 
19 (15 
DDwoR) 
(No) 
Mean 
31 
19f NR 
Own study 
criteria 
MRI 
Arthroscopy, N=11 
Arthrocentesis, N=8 
1 wk, 1, 3, 
6, 12, 24 
mo 
Pain, MMO, 
LM, PM, 
dietary 
alterations 
No 
Total=15 at 
24 mo 
(unclear) 
Schiffman et 
al. (1996) 
Random 
Double-
blind 
University, 
USA 
Yes 
27 
(No) 
Mean 
29 
3m,24f NR 
AACMDs 
and own 
criteriac 
None 
Active iontoph., N=9 
Control iontoph., N=9 
Placebo iontoph., N=9 
1 wk 
Pain (SSI), 
Function (CMI), 
MMO, LM 
Yes (N: 
unclear) 
None 
Goudot et al. 
(2000) 
Random NR 
University, 
France 
NR 
62 (54 
DDwoR) 
(No) 
Mean 
38 
75%f > 6mo 
Own study 
criteria 
MRI 
Arthroscopy, N=33 
Arthrocentesis, N=29 
12 mo Pain, MMO 
Total=4: 
(As=2, 
Ac=2) 
None 
Holmlund et 
al. (2001) 
Random NR 
University, 
Sweden 
NR 
22 (2 exc) 
(No) 
Mean 
34.5 
2m,18f 
Mean 14.5mo 
(range 2-
60mo) 
Own study 
criteria 
None 
Open surgery 
(Discectomy), N=10 
Arthroscopy, N=10/12 
3, 12 mo 
Pain, MMO, 
PM, MFIQ 
Yes (N: 
unclear, 
As=1) 
Total=2: 
(AS=2) 
Minakuchi et 
al. (2001) 
Report: 
Minakuchi et 
al. (2004) 
Random 
Single-
blind 
University, 
Japan 
Yes 
69 
(No) 
Mean 
34 
7m,62f 
Mean 98dy 
±SD 156.8dy 
Own study 
criteria 
MRI 
Education, N=21 
Self-management, N=23 
Combination therapy, 
N=25 
2, 4, 8 wk 
Pain, MMO, 
DAL, self-
questionnaire 
NR 
Total=10 
(Educ=2; 
SM=2; 
Comb=4; 
Unclear=2) 
(ITT used) 
Yuasa and 
Kurita (2001) 
Report: 
Yuasa et al. 
(2003) 
Random NR 
University, 
Japan 
NR 
60 
(Yes) 
Median
28 
12m,48f 
Median 84dy 
(range 16-
1254dy) 
AAOMS & 
IAOMS 
criteriad 
MRI 
Self-management, N=30 
No treatment, N=30 
2, 4 wk 
Pain, MMO, 
interference 
with daily life 
None 
Yes 
(unclear) 
(LOCF use) 
Maloney et al. 
(2002)e 
Random NR 
University, 
USA 
Yes 
24 DDwoR 
(No) 
NR NR NR RDC/TMD MRI 
Therabite+Splint, N=10 
WTDs+Splint, N=7 
Splint, N=7 
4 wk 
Pain, MMO, 
LM, PM 
NR No 
Peroz et al. 
(2004)e 
Random 
Double-
blind 
University, 
Germany 
Yes 
31 DDwoR 
(No) 
Mean 
44 
83%f ≥ 6mo RDC/TMD 
MRI in 
some 
patients 
Active PEMF, N=13/14 
Placebo PEMF, N=17 
9 dy, 6 wk, 
4 mo 
Pain, MMO, 
LM, PM, 
RDLA 
NR 
Total=1: 
(Active 
PEMF=1) 
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Appendix 3 (Table) (Continued) 
Study  
(year) 
Study design Participants 
Interventions 
Follow-up 
time-points 
Main assessed 
outcomes 
Adverse 
events 
Dropouts 
(groups) Allocation Blinding 
Setting, 
Country 
Fund 
Sample size 
(PA used?)a 
Age 
(years) 
Gender 
Locking 
duration 
Diagnostic 
criteria 
ST 
imaging 
Yoshida et al. 
(2005) 
Random NR 
University, 
Japan 
NR 
305 
(No) 
Range 
(18-74) 
76m,229f 
(range 1dy-
<1yr) 
Own study 
criteria 
None 
MM+NSAID, N=204 
NSAID, N=101 
Unclear (1 
wk) 
Pain, MMO NR NR 
Ismail et al. 
(2007) 
Random 
only data 
analyst 
University, 
Germany 
NR 
26 (21 
DDwoR) 
(Yes) 
Mean 
43 
3m,23f < 6mo RDC/TMD MRI 
Exercises+Splint, N=13 
Splint, N=13 
1 wk, 1, 2, 
3 mo 
Pain, MMO, 
PM 
NR No 
Politi et al. 
(2007) 
Random NR 
University, 
Italy 
NR 
20 
(No) 
Mean 
43 
6m,14f 
Mean 14.9mo 
(range 6-
27mo) 
Own study 
criteria 
MRI 
Open surgery 
(Condylectomy), N=10 
Arthroscopy, N=10 
12 mo 
Pain, MMO, 
PM, MFIQ 
Yes (N: 
unclear) 
No 
Schiffman et 
al. (2007) 
Report: 
Schiffman et 
al. (2014) 
Random 
Single-
blind 
University, 
USA 
Yes 
108 (2 exc) 
(Yes) 
Mean 
32 
8m,98f 
< 6mo and    
≥ 6mo 
Wilkes  
(III or IV) 
MRI 
Self-management, 
N=27/29 
Combination therapy, 
N=23/26 
Arthroscopy, N=24/27 
Open surgery 
(Arthroplasty), N=24/26 
3, 6, 12, 18, 
24, 60 mo 
Pain (SSI), 
Function (CMI), 
Therapy Cost 
Total=1 
(OS=1) 
Total=12: 
(Comb=3, 
AS=4, 
OS=5) 
(ITT used) 
Diracoglu et 
al. (2009) 
Alternatef 
(q-RCT) 
Single-
blind 
University, 
Turkey 
NR 
120 
(No) 
Mean 
34 
16m,104f  ≤ 3wk 
Own study 
criteria 
MRI 
Arthrocentesis, N=54/60 
Combination therapy, 
N=56/60 
1, 3, 6 mo 
Pain, MMO, 
LM, PM 
NR 
Total=10 
(unclear) 
Haketa et al. 
(2010)g 
Random 
Single-
blind 
University, 
Japan 
Yes 
52 
(Yes) 
Mean 
38 
6m,46f > 2wk 
Own study 
criteria 
MRI 
Self-management, 
N=19/24 
Splint, 25/28 
1, 2 mo 
Pain, MMO, 
LDF 
None 
Total=14: 
(SM=9; 
Splint=5) 
Yoshida et al. 
(2011) 
Report: 
Yoshida et al. 
(2013) 
Random NR 
University, 
Japan 
NR 
148 
(No) 
Mean 
40 
148f 
Mean 50dy 
(range 1-
360dy) 
Own study 
criteria 
None 
Self-MM, N=74 
No treatment, N=74 
10 min MMO, LM, PM NR NA 
Craane et al. 
(2012)g 
Random 
Single-
blind 
University, 
Belgium 
No 
49 
(Yes) 
Mean 
37 
2m,47f 
several wk to 
several yr 
RDC/TMD 
(IIb, IIc) 
MRI in 
only 6/49 
Jaw exercise, N=20/23 
Education, N=22/26 
3, 6, 12, 26, 
52 wk 
Pain, MMO, 
MFIQ 
NR 
Total=7: 
(Exer=3; 
Educ=4) 
(ITT used) 
Sahlstrom et 
al. (2013)g 
Random 
Single-
blind 
University, 
Sweden 
No 
45 
(Yes) 
Mean 
35 
4m,41f 
Median 24mo 
(range 3-
360mo) 
RDC/TMD MRI 
Arthrocentesis, N=14/20 
Extra-articular LA, 
N=23/25 
1, 3 mo 
Pain, MMO, 
JFLS 
None 
Total=8: 
(AC=6; 
LA=2) 
(ITT used) 
Abbreviations: AC: arthrocentesis, Arthrogr: arthrography, AS: arthroscopy, CMI: craniomandibular index, Comb: combination therapy of splints + physiotherapy + medication/education, C: control, DAL: daily activity limitations, Dx: 
diagnosis, dy: days, Educ: education, exc: excluded; exer: exercises, f: female, FOC: frequency of complaints, iontoph.: iontophoresis, ITT: intention-to-treat analysis, JFLS: jaw functional limitation scale, LA: local anaesthetic, LDF: 
limitation of daily functions, LM: lateral movement, LOCF: last observation carried forward,  m: male, MM: mandibular manipulation, MFIQ: mandibular function impairment questionnaire, MMO: maximum mouth opening, min: minutes, 
mm: millimetres, mo: months, MRI: magnetic resonance imaging, N: number, NA: not applicable, NR: not reported, NSAIDs: non-steroidal anti-inflammatory drugs, OS: open surgery, PA: power-analysis, PEMF: pulsed electromagnetic 
fields, PM: protrusive movement, PT: physiotherapy, q-RCT: quasi-randomised clinical trial, RDC/TMD: research diagnostic criteria of temporomandibular disorders, RDLA: restriction of daily life activities, SD: standard deviation, self-ex: 
self-exercise, SM: self-management, self-MM: self- mandibular manipulation, SSI: symptoms severity index, TENS: transcutaneous electric nerve stimulation, wk: weeks, WTDs: wooden tongue depressors, yr: years.  
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a A priori power-analysis was done in 7 RCTs. In the remaining 13 trials, a post-hoc power-analysis was performed using the G*3power statistical software (version 3) and 8 trials were found under-powered (<80%) for their level of 
significance for the two primary outcomes (pain and MMO) (Petersson et al., 1994; Linde et al., 1995; Schiffman et al., 1996; Holmlund et al., 2001; Minakuchi et al., 2001; Maloney et al., 2002; Peroz et al., 2004; Politi et al., 2007). 
b Criteria suggested by (Eriksson and Westesson, 1983). 
c Criteria suggested by American academy of craniomandibular disorders (AACMDs) in addition to own study’s authors criteria (Schiffman et al., 1989; McNeill, 1990).  
d Criteria suggested by American association of oral and maxillofacial surgeons (AAOMS) and international association of oral and maxillofacial surgeons (IAOMS) (surgery, 1984; Goss, 1993). 
e Separate data for DDwoR patients are available and/or obtained from the contacted authors (personal e-mail communication). 
f Patients were allocated to undergo either arthrocentesis or conservative treatment (a combination of splint and physiotherapy) according to their admission to the TMJ clinic (consecutively 1 to each group). 
g Statistical data (unpublished) were provided by the study authors (personal e-mail communication). 
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Appendix 4 (Figures): Risk of Bias 
 
Figure legends for Appendix 4: 
 
Appendix Figure 4.1. Summary Assessment for the Overall Risk of Bias*  
* Other bias: represents any other apparent bias in the trial design or conduct other than the already assessed biases in the 
tool (i.e., selection, performance and detection, attrition, and reporting biases) and it involves any concerns about bias in the 
included studies such as: baseline imbalance, blocked randomization in un-blinded trials, effects of funding sources ...etc. 
 
 
 
 
Appendix Figure 4.2. The Individual Domain Risk of Bias for Each Study*  
Symbols:   +   Low risk-of-bias,   ?   Unclear risk-of-bias,   -   High risk-of-bias. 
 
* Useful information and further clarifications about study design/conduct were obtained in the following studies (Petersson 
et al., 1994; Schiffman et al., 1996; Holmlund et al., 2001; Yuasa and Kurita, 2001; Schiffman et al., 2007). 
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Appendix 5 (Table). Description of interventions 
Intervention Description  
1. Non-invasive involves any conservative (non-surgical) interventions. 
 Patient education Includes information, explanation, and reassurance only. 
 Self-management Includes self-care instructions and advice plus medication 
(e.g., over-the-counter analgesic, NSAIDS, muscle relaxants) 
± self-exercises. 
 Splint therapy Includes different types of splints such as: stabilisation 
splints, repositioning splints, or soft splints. 
 Physiotherapy Includes different approaches of physical therapy such as: 
- Mandibular manipulation (MM): a ‘singular’ manual 
mandibular manipulation technique to ‘unlock’ the jaw and 
recapture the displaced disc (disc repositioning).   
- Jaw exercises: ‘repeated’ jaw ‘stretching’ exercises applied 
either by the patients themselves (home exercise programme 
‘self-exercises’) or by clinicians (professional exercise 
therapy ‘active or passive jaw exercises’). 
- Electro-physical modalities: ultrasound therapy, short wave 
diathermy, iontophoresis, transcutaneous electric nerve 
stimulation (TENS), pulsed electromagnetic fields (PEMF), 
or low level laser therapy (LLT). 
 Combination therapy Includes splints plus jaw exercises ± (self-care/medication/ 
education ± psychosocial ‘cognitive behavioural’ therapy 
‘CBT’). 
2. Minimally-invasive involves any intra-articular intervention by needles only. 
 Arthrocentesis A technique using needles and injections for joint hydraulic 
pumping and lavage inside the superior joint space. 
3. Invasive involves any surgical interventions. 
 Arthroscopic surgery A technique using an arthroscope for joint hydraulic pumping 
and lavage and/or any other operative arthroscopic operations 
inside the superior joint space. 
 Open joint surgery A technique using a skin incision to approach the 
temporomandibular joint such as discoplasty, discectomy, 
eminectomy, or condylectomy. 
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Appendix 6 (Tables). Statistical analysis for within-group difference from baseline for 
primary outcomes of each individual intervention. 
Appendix Table 6.1: Change from baseline for TMJ pain intensity (at jaw function) 
primary outcome. 
Studya  
(Year) 
Intervention 
Follow-up 
time-point 
Pre- 
treatment 
Post- 
treatment 
Changeb 
from baseline 
p-valuec for 
within-group 
difference 
from baseline 
Overall 
Risk-of-
Bias Mean ± SD Mean ± SD Mean ± SD 
Yoshida et al. 
(2005) 
MM 1 wk (ST) 45.5 29 -16.5 NR High 
NSAID only 1 wk (ST) NR NR NR NR High 
Yoshida et al. 
(2011) 
MM Outcome not 
assessed 
NA NA NA NA NA 
No treatment 
Craane et al. 
(2012)d 
Jaw exercises 3 mo (ST) 51.15 ± 12.91 21.63 ± 16.77 -29.52 ± 14.96 p<0.05 Unclear 
Education 3 mo (ST) 54.14 ± 15.93 17.82 ± 16.09 -36.32 ± 16.01 p<0.05 Unclear 
Jaw exercises 13 mo (LT) 51.15 ± 12.91 8.10 ± 10.46 -43.05 ± 11.75 p<0.05 Unclear 
Education 13 mo (LT) 54.14 ± 15.93 7.48 ± 9.55 -46.66 ± 13.13 p<0.05 Unclear 
Minakuchi et 
al. (2001) 
Combination therapy 2 mo (ST) 47.7 ± 25.2 26.2 ± 19.5 -21.5 ± 22.53 p<0.001 Unclear 
Self-management  2 mo (ST) 55.8 ± 25.8 24.6 ± 25.7 -31.2 ± 25.75 p<0.001 Unclear 
Education 2 mo (ST) 59.0 ± 24.0 29.0 ± 25.5 -30 ± 24.76 p<0.001 Unclear 
Yuasa and 
Kurita (2001) 
Self-management  1 mo (ST) Median 53.5 Median 25.5 Median -20 p<0.01 Unclear 
No treatment 1 mo (ST) Median 57 Median 22 Median -6 p<0.05 Unclear 
Haketa et al. 
(2010) 
Self-management  2 mo (ST) 63.1 ± 21.4 21.3 ± 26.4 -41.8 ± 24.04 p<0.001 Unclear 
Splint 2 mo (ST) 58.9 ± 28.2 36.5 ± 28.7 -22.4 ± 28.45 p<0.001 Unclear 
Lundh et al. 
(1992) 
Splint 12 mo (LT) NR NR NR NR High 
Control  12 mo (LT) NR NR NR NR High 
Linde et al. 
(1995) 
Splint 6 wk (ST) 51 NR NR p<0.001 High 
TENS 6 wk (ST) 63 NR NR p<0.001 High 
Maloney et al. 
(2002)e 
Jaw exercises + Splint 1 mo (ST) 49.41 ± 29.26 32.35 ± 26.37 -17.06 ± 27.85 p<0.05 High 
Splint 1 mo (ST) 44.29 ± 32.07 38.57 ± 24.10 -5.72 ± 28.37 NS High 
Ismail et al. 
(2007) 
Jaw exercises + Splint 3 mo (ST) 45 ± 20 NR -28 ± 21 p<0.05 Unclear 
Splint 3 mo (ST) 42 ± 22 NR -23 ± 22 p<0.05 Unclear 
Peroz et al. 
(2004)f 
Active PEMF 6 wk (ST) 44.82 ± 22.15 32.64 ± 25.54 -12.88 ± 23.91 p<0.01 Low 
Placebo PEMF 6 wk (ST) 48.50 ± 33.58 32.41 ± 25.94 -16.09 ± 30.00 p<0.01 Low 
Active PEMF 4 mo (LT) 44.82 ± 22.15 39.08 ± 25.82 -5.74 ± 24.10 p<0.05 Unclear 
Placebo PEMF 4 mo (LT) 48.50 ± 33.58 19.59 ± 25.43 -28.91 ± 29.79 p<0.05 Unclear 
Schiffman et 
al. (1996)g 
Active iontophoresis 1 wk (ST) 0.57 ± 0.1 0.47 ± 0.2 -0.10 ± 0.16 NS Unclear 
Placebo iontophoresis 1 wk (ST) 0.52 ± 0.2 0.50 ± 0.2 -0.02 ± 0.20 NS Unclear 
Schiffman et 
al. (2007) 
Self-management  3 mo (ST) 0.61 ± 0.23 0.33 ± 0.22 -0.28 ± 0.23 p<0.0001 Unclear 
Combination therapy 3 mo (ST) 0.72 ± 0.17 0.42 ± 0.27 -0.30 ± 0.23 p<0.0001 Unclear 
Arthroscopy 3 mo (ST) 0.70 ± 0.19 0.34 ± 0.25 -0.36 ± 0.22 p<0.0001 Unclear 
Open surgery 3 mo (ST) 0.76 ± 0.22 0.26 ± 0.24 -0.50 ± 0.23 p<0.0001 Unclear 
Self-management  60 mo (LT) 0.61 ± 0.23 0.23 ± 0.25 -0.38 ± 0.24 p<0.0001 Unclear 
Combination therapy 60 mo (LT) 0.72 ± 0.17 0.23 ± 0.23 -0.49 ± 0.20 p<0.0001 Unclear 
Arthroscopy 60 mo (LT) 0.70 ± 0.19 0.26 ± 0.20 -0.44 ± 0.20 p<0.0001 Unclear 
Open surgery 60 mo (LT) 0.76 ± 0.22 0.28 ± 0.25 -0.48 ± 0.24 p<0.0001 Unclear 
Petersson et al. 
(1994)h 
Arthrocentesis 2 mo (ST) 56.75 ± 20.14 33.63 ± 27.02 -23.12 ± 23.83 p<0.01 High 
Arthrography 2 mo (ST) 61.12 ± 18.23 49.65 ± 27.99 -11.47 ± 23.62 NS (p=0.06) High 
Sahlstrom et 
al. (2013)d 
Arthrocentesis 3 mo (ST) 60.6 ± 26.7 55.0 ± 30.7 -5.6 ± 28.77 NS Unclear 
ATN LA block 3 mo (ST) 58.1 ± 23.2 30.4 ± 22.6 -27.7 ± 22.90 p<0.0001 Unclear 
Diracoglu et al. 
(2009) 
Arthrocentesis 3 mo (ST) 62.6 ± 23.5 31.5 ± 25.2 -31.1 ± 23.3 p<0.01 High 
Combination therapy 3 mo (ST) 56.6 ± 24.7 50.8 ± 24.2 -6.2 ± 15.8 p<0.01 High 
Arthrocentesis 6 mo (LT) 62.6 ± 23.5 15.1 ± 18.2 -47.4 ± 21.4 p<0.01 High 
Combination therapy 6 mo (LT) 56.6 ± 24.7 43.9 ± 23.1 -12.2 ± 17.6 p<0.01 High 
Fridrich et al. 
(1996) 
Arthroscopy 6-24 mo (LT) 64.5 17 -47.5 p<0.05 High 
Arthrocentesis 6-24 mo (LT) 66 23 -43 p<0.05 High 
Goudot et al. 
(2000) 
Arthroscopy 12 mo (LT) 57 ± 9 19 ± 24 -38 ± 24 p<0.0001 High 
Arthrocentesis 12 mo (LT) 56 ± 8 9 ± 21 -47 ± 21 p<0.0001 High 
Holmlund et al. 
(2001) 
Open surgery 12 mo (LT) 62 ± 28.2 6 ± 12.7 -56 ± 21.87 p<0.001 High 
Arthroscopy 12 mo (LT) 71 ± 9.9 25 ± 32.1 -46 ± 23.75 p<0.01 High 
Politi et al. 
(2007) 
Open surgery 12 mo (LT) 80 ± 13.3 13 ± 12.5 -67 ± 13.15 p<0.01 High 
Arthroscopy 12 mo (LT) 79 ± 12 19 ± 18.5 -60 ± 15.59 p<0.01 High 
Abbreviations: ATN LA block: auriculotemporal nerve local anaesthesia block, LT: long-term, MM: mandibular manipulation, mo: months, 
NA: not-applicable, NR: not-reported, NS: non-significant, NSAID: non-steroidal anti-inflammatory drug, PEMF: pulsed electromagnetic 
fields, ST: short-term, TENS: transcutaneous electric nerve stimulation, wk: weeks.  
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a Studies are ordered in accordance with the study order in the summary of findings table (Table 1). 
b Mean change and Standard deviation (SD) for mean change were reported in only three studies (Goudot et al., 2000; Ismail et al., 2007; 
Diracoglu et al., 2009). In the remaining studies, difference in means and SD for difference were calculated using an Excel sheet (version 
14.0) by applying the following formulae: [𝑀𝑒𝑎𝑛change from baseline = 𝑀𝑒𝑎𝑛post – 𝑀𝑒𝑎𝑛pre], and [𝑆𝐷change from baseline = √(𝑆𝐷𝑝𝑟𝑒)2 + (𝑆𝐷𝑝𝑜𝑠𝑡)2/2 ] 
(Markiewicz et al., 2008; Fritz et al., 2012; Katsnelson et al., 2012) respectively. 
c Statistical significance (p-value<0.05) for within-group statistical difference from baseline as reported in the studies. In Petersson et al. 
(1994), the p-value was not reported, but was calculated by the Paired T-Test for summarised data (mean differences) using Minitab 
statistical package (version 16). 
d Unpublished statistical data were provided by the study authors (personal e-mail communication). 
e Therabite + splint group and WTDs + splint group were merged together as one group  jaw exercises + splint. 
f Separate data for DDwoR patients are available and/or obtained from the contacted authors (personal e-mail communication). 
g Only comparison between active iontophoresis by dexamethasone + lidocaine and placebo iontophoresis by normal saline was considered 
and reported. 
h Estimated from Figure 2 in the published trial.
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Appendix Table 6.2: Change from baseline for maximum mouth opening 
(unassisted/active MMO) primary outcome. 
Studya  
(Year) 
Intervention 
Follow-up 
time-point 
Pre- 
treatment 
Post- 
treatment 
Changeb 
from baseline 
p-valuec for 
within-group 
difference 
from baseline 
Overall 
Risk-of-
Bias Mean ± SD Mean ± SD Mean ± SD 
Yoshida et al. 
(2005) 
MM 1 wk (ST) 26.5 33.25 +6.75 NR High 
NSAID only 1 wk (ST) 28.4 28.4 0 NS High 
Yoshida et al. 
(2011)d 
MM 10 min (ST) 27 ± 3.83   38 ± 3.83 +11 ± 3.83  p<0.001 High 
No treatment 10 min (ST) 29 ± 2.5 30 ± 3.17   +1 ± 2.85 p<0.01 High 
Craane et al. 
(2012)e 
Jaw exercises 3 mo (ST) 35.8 ± 7.4  39.4 ± 6.3   +3.6 ± 6.87 p<0.05 Unclear 
Education 3 mo (ST)  36.2 ± 7.1  42.5 ± 6.9 +6.3 ± 7.0  p<0.05 Unclear 
Jaw exercises 13 mo (LT) 35.8 ± 7.4  42.7 ± 5.7   +7.8 ± 6.2 p<0.05 Unclear 
Education 13 mo (LT)  36.2 ± 7.1  46.5 ± 7.1 +10.1 ± 8.2  p<0.05 Unclear 
Minakuchi et 
al. (2001) 
Combination therapy 2 mo (ST) 33.6 ± 9.68  42.4 ± 10.1  +8.8 ± 9.89  p<0.001 Unclear 
Self-management  2 mo (ST)  36.1 ± 9.98  39.6 ± 10.2  +3.5 ± 10.09 p<0.001 Unclear 
Education 2 mo (ST)  36.7 ± 10.36  41 ± 8.39  +4.3 ± 9.43 p<0.001 Unclear 
Yuasa and 
Kurita (2001) 
Self-management  1 mo (ST) Median 29 Median 37.5 Median +7  p<0.0001 Unclear 
No treatment 1 mo (ST) Median 30 Median 33.5  Median +1.5 p<0.05 Unclear 
Haketa et al. 
(2010) 
Self-management  2 mo (ST)  32.2 ± 5.5 41.0 ± 5.4   +8.8 ± 5.45 p<0.001 Unclear 
Splint 2 mo (ST) 30.3 ± 7.7   35.0 ± 5.8 +4.7 ± 6.82  p<0.001 Unclear 
Lundh et al. 
(1992) 
Splint Outcome not 
assessed  
NA NA NA NA NA 
Control  
Linde et al. 
(1995) 
Splint 6 wk (ST) NR NR +5.9 ± 4.18  p<0.0001 High 
TENS 6 wk (ST) NR NR +6.06 ± 6.72 p<0.01 High 
Maloney et al. 
(2002)f 
Jaw exercises + Splint 1 mo (ST) 28.06 ± 3.51 34 ± 4.61  +5.94 ± 4.1 p<0.01 High 
Splint 1 mo (ST) 28.29 ± 6.05  29.86 ± 6.47 +1.57 ± 6.26 NS High 
Ismail et al. 
(2007) 
Jaw exercises + Splint 3 mo (ST)  30.1 ± 5.4 40.8 ± 4.1   +10.4 ± 5.4 p<0.05 Unclear 
Splint 3 mo (ST) 28.6 ± 5.8   35.9 ± 4.8 +7.3 ± 6.2  p<0.05 Unclear 
Peroz et al. 
(2004)g 
Active PEMF 6 wk (ST) 32.25 ± 9.5  36.71 ± 8.36  +4.46 ± 8.95  p<0.05 Low 
Placebo PEMF 6 wk (ST)  35 ± 7.7  39.18 ± 7.87  +4.18 ± 7.79 p<0.05 Low 
Active PEMF 4 mo (LT) 32.25 ± 9.5  38 ± 7  +5.57 ± 8.34  p<0.05 Unclear 
Placebo PEMF 4 mo (LT)  35 ± 7.7 39 ± 7.1  +4.0 ± 7.41 p<0.05 Unclear 
Schiffman et 
al. (1996)h 
Active iontophoresis 1 wk (ST) 32.2 ± 6.5  38.2 ± 10.2  +6 ± 8.55  p<0.05 Unclear 
Placebo iontophoresis 1 wk (ST) 34 ± 7.8  36.3 ± 5.6   +2.3 ± 6.8  NS Unclear 
Schiffman et 
al. (2007) 
Self-management  3 mo (ST) NR NR NR p<0.0001 Unclear 
Combination therapy 3 mo (ST) NR NR NR p<0.0001 Unclear 
Arthroscopy 3 mo (ST) NR NR NR p<0.0001 Unclear 
Open surgery 3 mo (ST) NR NR NR p<0.0001 Unclear 
Self-management  60 mo (LT) NR NR NR p<0.0001 Unclear 
Combination therapy 60 mo (LT) NR NR NR p<0.0001 Unclear 
Arthroscopy 60 mo (LT) NR NR NR p<0.0001 Unclear 
Open surgery 60 mo (LT) NR NR NR p<0.0001 Unclear 
Petersson et al. 
(1994) 
Arthrocentesis 2 mo (ST) 27.4 ± 6.0  32.6 ± 10.8  +5.2 ± 8.74  p<0.05 High 
Arthrography 2 mo (ST) 30.7  ± 8.1 35.6  ± 8.1 +4.9 ± 8.1 p<0.05 High 
Sahlstrom et 
al. (2013)e 
Arthrocentesis 3 mo (ST) 34.4 ± 7.2  37.8 ± 7.4 +3.4 ± 7.3  NS Unclear 
ATN LA block 3 mo (ST) 33.1 ± 9.1 42.7 ± 8.1  +9.6 ± 8.61 p<0.05 Unclear 
Diracoglu et al. 
(2009) 
Arthrocentesis 3 mo (ST) 31.20 ± 7.03 35.13 ± 6.72  +3.92 ± 6.10  p<0.01 High 
Combination therapy 3 mo (ST)  29.89 ± 4.82  33.20 ± 7.61  +4.17 ± 7.80 p<0.01 High 
Arthrocentesis 6 mo (LT) 31.20 ± 7.03 37.89 ± 6.53  +6.68 ± 6.20  p<0.01 High 
Combination therapy 6 mo (LT)  29.89 ± 4.82  35.54 ± 6.41  +6.20 ± 6.50 p<0.01 High 
Fridrich et al. 
(1996) 
Arthroscopy 6-24 mo (LT) 30 ± 8.7  47.5 ± 4.7  +17.5 ± 6.99  p<0.0001 High 
Arthrocentesis 6-24 mo (LT) 33  ± 12.2 41 ± 4.9 +8 ± 9.3 p<0.05 High 
Goudot et al. 
(2000) 
Arthroscopy 12 mo (LT) 29 ± 4.8   38.6 ± 4.2  +9.6 ± 5.8  p<0.0001 High 
Arthrocentesis 12 mo (LT)  29.4 ± 3.1  33.8 ± 4.4   +4.3 ± 4.4 p<0.0001 High 
Holmlund et al. 
(2001) 
Open surgery 12 mo (LT) NR NR NR p<0.001 High 
Arthroscopy 12 mo (LT) NR NR NR p<0.01 High 
Politi et al. 
(2007) 
Open surgery 12 mo (LT) NR NR NR p<0.01 High 
Arthroscopy 12 mo (LT) NR NR NR p<0.01 High 
Abbreviations: ATN LA block: auriculotemporal nerve local anaesthesia block, LT: long-term, min: minutes, MM: mandibular 
manipulation, mo: months, NA: not-applicable, NR: not-reported, NS: non-significant, NSAID: non-steroidal anti-inflammatory drug, 
PEMF: pulsed electromagnetic fields, ST: short-term, TENS: transcutaneous electric nerve stimulation, wk: weeks.  
a Studies are ordered in accordance with the study order in the summary of findings table (Table 1). 
b Mean change and Standard deviation (SD) for mean change were reported in five studies (Linde et al., 1995; Goudot et al., 2000; Ismail et 
al., 2007; Diracoglu et al., 2009; Craane et al., 2012). In the remaining studies, difference in means and SD for difference were calculated 
using an Excel sheet (version 14.0) by applying the following formulae: [𝑀𝑒𝑎𝑛change from baseline = 𝑀𝑒𝑎𝑛post – 𝑀𝑒𝑎𝑛pre], and [𝑆𝐷change from baseline 
= √(𝑆𝐷𝑝𝑟𝑒)2 + (𝑆𝐷𝑝𝑜𝑠𝑡)2/2 ] (Markiewicz et al., 2008; Fritz et al., 2012; Katsnelson et al., 2012) respectively. 
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c Statistical significance (p-value <0.05) for within-group statistical difference from baseline as reported in the studies. In Fridrich et al. 
(1996), the p-value was not reported, but was calculated by the Paired T-Test for summarised data (mean differences) using Minitab 
statistical package (version 16). 
d Mean (SD) were calculated from the reported median (range) in the published trial according to (Hozo et al., 2005). 
e Unpublished statistical data were provided by the study authors (personal e-mail communication). 
f Therabite + splint group and WTDs + splint group were merged together as one group  jaw exercises + splint. 
g Separate data for DDwoR patients are available and/or obtained from the contacted authors (personal e-mail communication). 
h Only comparison between active iontophoresis by dexamethasone + lidocaine and placebo iontophoresis by normal saline was considered 
and reported. 
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